What Is Genelux Corporation (GNLX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Genelux Corporation's intrinsic value is estimated at $0.95, suggesting the stock is overvalued at its current price of $2.91. With 8 out of 9 models flagging downside (-67.2% average return), the market may be pricing in unsustainable growth. Notably, PWERM sees the most upside at +0.7% (fair value: $2.93), while Sentiment SOTP is the most conservative at -94.2% ($0.17). The spread between these extremes — +94.9% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About GNLX?
9 of 13 models are currently active for GNLX. Of these, 1 model suggests upside while 8 models suggest overvaluation. The Bayesian DCF estimates GNLX's intrinsic value at $1.20, implying -58.9% downside from the current price. See which stocks rank higher →
How Does GNLX Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, GNLX ranks #171 by Quality of Company score. CirclFi's QOC score of 5.4/10 evaluates 32 fundamental signals. A score of 5.4 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a healthcare company, Genelux Corporation operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating GNLX should weigh these sector-specific dynamics alongside our model-derived fair values.
Is GNLX a Value Trap?
CirclFi's Value Trap algorithm assigns GNLX a score of 16/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Genelux Corporation. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Genelux Corporation's fundamental quality profile registers 5.4/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +94.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every GNLX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across GNLX's 9 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad